Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Concert Pharma To Get $300M+ Per Drug in Celgene Pact 05/06/13 Boston
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
Concert Pharma, Jazz Pharma Strike $120M Deal for Narcolepsy 02/26/13 Boston
BG Medicine, Bottomline, 4s3 Bioscience Among the Week’s Dealmakers 03/07/12 Boston
Concert, Alere, TremRx, & More Names from Boston Life Sciences News 03/02/12 Boston
SD Life Sciences (and Cleantech) Roundup: DexCom, Ligand, Genomatica 03/01/12 San Diego
Concert Nabs $200M Deal From Avanir to Make Psych Drugs 02/29/12 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex 08/04/10 Boston
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News 07/16/10 Boston
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug 07/14/10 Boston
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms 06/07/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC 04/22/10 Boston
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm 04/21/10 Boston
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer 04/20/10 San Diego
Sirtris Founders Build New Venture Capital Fund, Keep Mum 02/12/10 Boston
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News 11/13/09 Boston
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill 11/09/09 Boston
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List 07/21/09 Boston
E Ink Scooped up by Taiwanese Display Maker, EMC Battles NetApp For Data Domain, Polatis Picks Up $8M, & More Boston-Area Deals News 06/05/09 Boston
Page 1 of 2 next page »